Protocol summary

Study aim
Comparison of the effect of ultrasound guided intra-articular injection of corticosteroids and platelet-riched plasma in the treatment of rotator cuff tendinopathy
Design
A double-blind clinical trial on 60 patients, simple randomization using the random numbers table, phase 3, with two parallel case and control groups.
Settings and conduct
In this double-blind clinical trial study, all patients diagnosed with tendinopathy without complete tendon rupture who refer to Shahid Beheshti Hospital are included in the study.
Participants/Inclusion and exclusion criteria
Inclusion criteria: shoulder pain for more than three months, tendinopathy and partial tear of rotator cuff tendons, MRI findings of tendinopathy or incomplete rotator cuff tear and exclusion criteria: complete tear of cuff tendons, history of shoulder surgery in 6 In the last month, the presence of rheumatological inflammatory diseases, the presence of shoulder instability based on examinations, the history of corticosteroid injection in the shoulder joint during the past 3 months, the history of PRP treatment in the past 6 months, the lack of patient satisfaction.
Intervention groups
In the first group of PRP injections, by taking 35 cc of venous blood with 5 cc of EDTA, it was divided equally into 4 tubes, and the first round was performed for 10 minutes at a speed of 1600 rpm, and then the plasma It enters two pipes and the second round is done at a speed of 3500 rpm for 6 minutes. In this case, 6 cc of liquid containing platelets with a concentration of 5 to 6 times is obtained, which is divided into two syringes in the amount of 3 cc. 3 cc of it is injected intra-articularly at an angle of 30-45 degrees from posterolateral. The second group receives corticosteroid injection in the form of methylprednisolone 40 mg intra-articularly.
Main outcome variables
Shoulder pain and range of motion

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20221029056333N3
Registration date: 2023-04-28, 1402/02/08
Registration timing: registered_while_recruiting

Last update: 2023-04-28, 1402/02/08
Update count: 0
Registration date
2023-04-28, 1402/02/08
Registrant information
Name
Mehdi Tavasoli
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 11 3225 6285
Email address
m.tavasoli@mubabol.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-04-10, 1402/01/21
Expected recruitment end date
2023-06-11, 1402/03/21
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effect of ultrasound guided intra-articular injection of corticosteroids and platelet-riched plasma in the treatment of rotator cuff tendinopathy
Public title
Effect of ultrasound guided intra-articular injection of corticosteroids and platelet-riched plasma in the treatment of rotator cuff tendinopathy
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Shoulder pain that lasts more than three months Tendinopathy and partial rupture of rotator cuff tendons MRI findings of tendinopathy or incomplete rotator cuff tear
Exclusion criteria:
Complete rupture of rotator cuff tendons History of shoulder surgery in the last 6 months Presence of rheumatological inflammatory diseases Shoulder instability is based on examinations The history of corticosteroid injection in the shoulder joint in the last 3 months History of PRP treatment in the last 6 months Dissatisfaction of patients
Age
From 40 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
People included in the study will be randomized by simple random method. Tables of random numbers found in many statistical reference books will be used to randomize the numbers. Numbers between 0 and 24 are assigned to the first group, numbers between 25 and 49 are assigned to the second group. The study group includes Cortone and PRP. Concealment is done in consecutively numbered, sealed, opaque envelopes and is kept by the department secretary.
Blinding (investigator's opinion)
Double blinded
Blinding description
This study is a double-blind clinical trial in which the participant, the outcome assessor and the data analyst will be unaware of the treatment process. After randomization, the patients of each treatment group are introduced by researcher 1 (one of the executive residents) to researcher 2 to evaluate the outcome. Researcher 2 (one of the supervisors) is only an outcome assessor and records the results without knowing the type of treatment and its effects. A person who is an information analyst (statistician) also receives the recorded information at the end of the work and is not in the process of the intervention groups in any way. Patients also do not know about the injectable substance. Blood is taken from all patients. Plasma in two intervention groups is drawn in a covered syringe.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Health Research Institute - Ethics Committee of Babol University of Medical Sciences
Street address
Babol University of Medical Sciences, Ganjafrooz Street, Babol, Mazandaran, Iran
City
Babol
Province
Mazandaran
Postal code
4716681451
Approval date
2023-03-12, 1401/12/21
Ethics committee reference number
IR.MUBABOL.HRI.REC.1401.287

Health conditions studied

1

Description of health condition studied
Rotator cuff tendinopathy
ICD-10 code
M75.1
ICD-10 code description
Rotator cuff tear or rupture, not specified as traumatic

Primary outcomes

1

Description
Pain
Timepoint
Before treatment and 1, 2, 3, and 6 months after the start of treatment
Method of measurement
Using the VAS scale & record severe pain intensity

2

Description
Shoulder range of motion
Timepoint
Before treatment and 1, 2, 3, and 6 months after the start of treatment
Method of measurement
By goniometer

Secondary outcomes

1

Description
Patients' performance
Timepoint
Before treatment and 1, 2, 3, and 6 months after the start of treatment
Method of measurement
Disabilities of the Arm, Shoulder and Hand Outcome یا DASH

Intervention groups

1

Description
Intervention group: For this group, PRP injection is performed. In this method, the patient had one PRP injection. In this group, 35 cc of venous blood was taken along with 5 cc of EDTA (Ethylenediaminetetra-acetic acid) and divided equally into 4 tubes. And by Royagen centrifuge machine, the first round is done for 10 minutes at a speed of 1600 rpm and then the obtained plasma enters two tubes and the second round will be done at a speed of 3500 rpm for 6 minutes. In this case, 6 cc of liquid containing platelets with 5 to 6 times concentration will be obtained. The samples will be sent to the laboratory before and after centrifugation to prove platelet concentration. Then, 6 cc of the obtained liquid is divided into two syringes with 3 cc each. 3 cc of that injection is performed by a resident project manager intra-articularly with an angle of 30-45 degrees from posterolateral.
Category
Treatment - Drugs

2

Description
Control group: This group receives corticosteroid injection in the form of methylprednisolone (depomedrol) 40 mg intra-articularly.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Shahid Beheshti Hospital
Full name of responsible person
Dr. Mehdi Tavasoli
Street address
Babol University of Medical Sciences, Ganjafrooz Street, Babol, Mazandaran, Iran
City
Babol
Province
Mazandaran
Postal code
4716681451
Phone
+98 11 3225 6285
Email
m.tavasoli@mubabol.ac.ir
Web page address
http://www.mubabol.ac.ir/

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Dr. Mehdi Rajabnia
Street address
Babol University of Medical Sciences, Ganjafrooz Street, Babol, Mazandaran, Iran
City
Babol
Province
Mazandaran
Postal code
4716681451
Phone
+98 11 3219 7667
Email
ramazan@yahoo.com
Web page address
http://www.mubabol.ac.ir/
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Babol University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Dr. Mehrdad Mostafalo
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Radiology
Street address
Babol University of Medical Sciences; Ganjafrooz Street; Babol; Iran
City
Babol
Province
Mazandaran
Postal code
4716681451
Phone
+98 11 3225 6285
Email
mostafa_mehrdad@yahoo.com
Web page address
http://www.mubabol.ac.ir/

Person responsible for scientific inquiries

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Dr. Mehdi Tavasoli
Position
Assisstant professor
Latest degree
Specialist
Other areas of specialty/work
Orthopedics
Street address
Babol University of Medical Sciences; Ganjafrooz Street; Babol; Iran
City
Babol
Province
Mazandaran
Postal code
4716681451
Phone
+98 11 3225 6285
Email
Mehdi.tavasolii@gmail.com
Web page address
http://www.mubabol.ac.ir/

Person responsible for updating data

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Dr. Mehdi Tavasoli
Position
Assisstant professor
Latest degree
Specialist
Other areas of specialty/work
Orthopedics
Street address
Babol University of Medical Sciences; Ganjafrooz Street; Babol; Iran
City
Babol
Province
Mazandaran
Postal code
4716681451
Phone
+98 11 3225 6285
Email
Mehdi.tavasolii@gmail.com
Web page address
http://www.mubabol.ac.ir/

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
.
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Loading...